BioXcel looks to expand label to at-home use for lead psych drug. Initial data are mixed
BioXcel reported Thursday morning that Igalmi, a drug approved to treat agitation in patients with certain psychiatric disorders …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
